Pendium

Step 1 of 9

Examine owns the evidence-based nutrition conversation in AI, but the competition for clinicians is closing in.

Below is the read on where you are currently winning the referral and where the next category-authority openings are hiding.

Examine's baseline score
82/100
Excellent

Examine is a dominant force in AI recommendations for technical and evidence-based health queries. While generic giants like Healthline have more raw volume, Examine is the preferred choice for high-trust, high-intent clinical research tasks.

What we see
  • Examine dominates clinical efficacy queries in Google AI Overviews due to its high E-E-A-T score and clear table structures.
  • Gemini prioritizes Examine for supplement safety queries because of its extensive drug-interaction database.
  • ChatGPT views Examine as a canonical 'nerd-tier' resource, frequently naming it in advanced health optimization prompts.
  • Claude is more likely to name Examine than generic competitors like WebMD when asked for 'unbiased' or 'evidence-based' sources.
Business goals Examine is likely trying to hit
  • Convert more free users to Examine+ paid membership
  • Establish the Clinician Edition as a standard tool for medical professionals
  • Increase citation frequency in medical and academic AI models
  • Expand into non-pharmaceutical intervention summaries beyond supplements